Cessation Therapeutics
Developer of immunotherapy based vaccines to manage addictions
Funding snapshot
About
Developer of immunotherapy based vaccines to manage addictions. It offer drug conjugate vaccine molecules to overcome addictions such as overcome the opioid, heroin, morphine, fentanyl, alcohol and nicotine addiction use disorders. It contains drug-like “hapten” linked to an immunogenic protein and formulated with immune-stimulating substances directing the immune system to produce antibodies and induce immunity to drugs of abuse.
Latest news
No articles yet.
Similar startups
NovaHealth AI
Clinical documentation copilot for ambulatory care networks in the US.
Statiq
Manufacturer of electric vehicle charging hardware and operator of networks
Spyne.ai
Platform offering AI-powered imaging for vehicle photography
Immuneel
Developer of T-cell therapies for the treatment of cancer
Raising like Cessation Therapeutics?
Analyze your pitch deck before your next raise.
Analyze My Deck →